Related Experiment Videos
Nosocomial pneumonia in pediatric patients: practical problems and rational solutions
1Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, 46 Sawkins Road, Cape Town, South Africa. heather@rmh.uct.ac.za
Insights
Hospital-acquired pneumonia in children is a serious infection. Early, appropriate antibiotic treatment and infection control measures are crucial for reducing mortality and preventing the spread of resistant bacteria.
Area of Science:
- Pediatric Infectious Diseases
- Hospital Epidemiology
- Antimicrobial Stewardship
Background:
- Nosocomial pneumonia is a frequent and often fatal hospital-acquired infection in children.
- Risk factors include intensive care unit admission, intubation, and chronic illnesses.
- Viruses like RSV are common, but Gram-negative bacteria pose a high mortality risk.
Purpose of the Study:
- To review the epidemiology, diagnosis, treatment, and prevention of pediatric nosocomial pneumonia.
- To highlight the challenges posed by multiresistant pathogens.
- To provide guidance on empiric therapy and infection control.
Main Methods:
- Literature review of nosocomial pneumonia in pediatric populations.
- Analysis of causative pathogens, risk factors, and treatment outcomes.
- Synthesis of current recommendations for diagnosis and management.
Main Results:
- Gram-negative bacteria and Staphylococcus aureus are key pathogens, with increasing antimicrobial resistance.
- Diagnosis relies on clinical, radiological, and microbiological data.
- Effective empiric therapy requires broad-spectrum coverage tailored to local resistance patterns.
Conclusions:
- Prompt and appropriate empiric treatment is vital for reducing morbidity and mortality.
- Infection control measures, including hand hygiene and judicious antibiotic use, are essential for prevention.
- Addressing multiresistant organisms requires a multi-faceted approach involving healthcare providers and policymakers.
Abstract:
Nosocomial pneumonia is a common hospital-acquired infection in children, and is often fatal. Risk factors for nosocomial pneumonia include admission to an intensive care unit, intubation, burns, surgery, and underlying chronic illness. Viruses, predominantly respiratory syncytial virus (RSV), are the most common cause of pediatric nosocomial respiratory tract infections. Gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa) are the predominant bacterial pathogens, and are associated with a high mortality rate. Staphylococcus aureus and Staphylococcus epidermidis are the most common Gram-positive bacteria causing nosocomial pneumonia; infections with these organisms have a better outcome than those with Gram-negative organisms. An increasing problem is the emergence of multiresistant Gram-positive and Gram-negative nosocomial pathogens. Distinguishing nosocomial pneumonia from other pulmonary processes may be difficult; diagnosis is based on clinical signs, radiological findings, and microbiological results. Recommended empiric therapy should consider factors such as the time of onset of illness, severity of disease, and specific risk factors for nosocomial pneumonia, including use of mechanical ventilation, underlying disease, or recent use of antibacterials. The resident local hospital flora should be considered when selecting therapy for nosocomial pneumonia. Early initiation of appropriate empiric therapy reduces morbidity and mortality. For empiric treatment of bacterial nosocomial pneumonia, an intravenous antibacterial regimen that includes coverage of Gram-negative bacilli and Gram-positive organisms should be used. A carbapenem or ureidopenicillin derivative (piperacillin) plus a beta-lactamase inhibitor should be used where extended spectrum beta-lactamase-producing Enterobacteriaceae are endemic. Therapy should be modified when a specific pathogen and its antimicrobial susceptibility are identified. Effective prevention of nosocomial pneumonia requires infection control measures that affect the environment, personnel, and patients. Of these, hand hygiene, appropriate infection control policies, and judicious use of antibacterials are essential.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmacokinetics in Pediatric Patients: Drug Excretion